The Hair Loss Encyclopedia

Search

for
Search:

GlossaryErlotinib

medication that inhibits cancer cell growth by targeting EGFR

Erlotinib is a medication used to treat certain types of cancer, such as non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By blocking this receptor, erlotinib can help slow down or stop the progression of the disease.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 221 results

research Persistent Hair Growth During Treatment With the EGFR Inhibitor Erlotinib

39 citations , March 2009 in “Dermatology Online Journal”

Erlotinib can cause persistent excessive hair growth.

research A Case Report of Inflammatory Nonscarring Alopecia Associated with the Epidermal Growth Factor Receptor Inhibitor Erlotinib

33 citations , June 2009 in “Journal of Cutaneous Pathology”

Erlotinib can cause nonscarring hair loss and itchy skin.

research Folliculitis Decalvans Associated with Erlotinib

25 citations , April 2010 in “Clinical and Experimental Dermatology”

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

research A Case of Cicatricial Alopecia Associated with Erlotinib

25 citations , January 2011 in “Annals of Dermatology”

Erlotinib can cause hair loss as a side effect.

research Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture

15 citations , October 2014 in “The journal of investigative dermatology/Journal of investigative dermatology”

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

View more "erlotinib" in research →

Community Join

0 / 0 results

— no results